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Studies using univariate analysis from China, Italy and the USA, as well as multivariate analysis from USA and UK have shown that people with diabetes have a higher risk of more adverse outcomes from COVID‐19 compared with people without diabetes. However, the differential risks between type 1 versus type 2 diabetes remains unreported. Using data from the COVID patient notification system, UK investigators have studied the relative and absolute risk of in‐hospital related death with COVID‐19 in people with type 1 and type 2 diabetes. There were 23,804 hospital deaths with COVID‐19 in England reported to 11th May 2020. Overall, one third of these deaths occurred in people with diabetes. Adjusted for age, sex, deprivation, ethnicity and geographical regions, people with type 1 and type 2 diabetes had 3.5 and 2.03 times the relative risk of dying in hospital from COVID‐19 compared to those without diabetes. To put this into context however, age appears to be a major factor for people with diabetes at risk of death with COVID‐19. Mean age of death in type 1 diabetes was 72 years and type 2 diabetes was 77.9 years. Moreover, the odd ratio for death in people \<40 years was 0.01, whereas for people \>80 years was 9.14 (both relative to reference age group of 60‐69 years. Additional important risk factors which adjusted and increases the risk of in‐patient death with COVID‐19 in people with type 1 and type 2 diabetes are social deprivation, British Asian Minority ethnic (BAME) group and presence of comorbidities such as coronary heart disease, cerebrovascular disease and heart failure.
